11-99819775-A-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_014361.4(CNTN5):​c.277+10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.0070 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0041 ( 0 hom. )

Consequence

CNTN5
NM_014361.4 intron

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.495

Publications

0 publications found
Variant links:
Genes affected
CNTN5 (HGNC:2175): (contactin 5) The protein encoded by this gene is a member of the immunoglobulin superfamily, and contactin family, which mediate cell surface interactions during nervous system development. This protein is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein that functions as a cell adhesion molecule. It may play a role in the formation of axon connections in the developing nervous system. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-99819775-A-G is Benign according to our data. Variant chr11-99819775-A-G is described in ClinVar as [Benign]. Clinvar id is 3054065.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN5NM_014361.4 linkc.277+10A>G intron_variant Intron 4 of 24 ENST00000524871.6 NP_055176.1 O94779-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN5ENST00000524871.6 linkc.277+10A>G intron_variant Intron 4 of 24 1 NM_014361.4 ENSP00000435637.1 O94779-1

Frequencies

GnomAD3 genomes
AF:
0.00707
AC:
67
AN:
9480
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.137
Gnomad EAS
AF:
0.00382
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0420
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00245
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0118
AC:
133
AN:
11318
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.183
Gnomad EAS exome
AF:
0.00206
Gnomad FIN exome
AF:
0.0471
Gnomad NFE exome
AF:
0.00895
Gnomad OTH exome
AF:
0.00472
GnomAD4 exome
AF:
0.00408
AC:
457
AN:
112034
Hom.:
0
Cov.:
4
AF XY:
0.00426
AC XY:
234
AN XY:
54982
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2652
American (AMR)
AF:
0.00
AC:
0
AN:
5980
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
154
AN:
1452
East Asian (EAS)
AF:
0.00141
AC:
13
AN:
9196
South Asian (SAS)
AF:
0.00361
AC:
33
AN:
9140
European-Finnish (FIN)
AF:
0.0419
AC:
148
AN:
3532
Middle Eastern (MID)
AF:
0.00197
AC:
1
AN:
508
European-Non Finnish (NFE)
AF:
0.00104
AC:
78
AN:
75136
Other (OTH)
AF:
0.00676
AC:
30
AN:
4438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00704
AC:
67
AN:
9520
Hom.:
0
Cov.:
0
AF XY:
0.00915
AC XY:
46
AN XY:
5028
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2406
American (AMR)
AF:
0.00
AC:
0
AN:
1642
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
20
AN:
146
East Asian (EAS)
AF:
0.00382
AC:
5
AN:
1310
South Asian (SAS)
AF:
0.00
AC:
0
AN:
568
European-Finnish (FIN)
AF:
0.0420
AC:
36
AN:
858
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
16
European-Non Finnish (NFE)
AF:
0.00245
AC:
6
AN:
2452
Other (OTH)
AF:
0.00
AC:
0
AN:
112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000898
Hom.:
0
Bravo
AF:
0.000234

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CNTN5-related disorder Benign:1
May 21, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
13
DANN
Benign
0.75
PhyloP100
0.49
PromoterAI
0.035
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201079661; hg19: chr11-99690506; API